Clinical Trials Directory

Trials / Unknown

UnknownNCT04807686

Attenuation of Tonal Tinnitus by Lateral Inhibition Therapy

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
29 (estimated)
Sponsor
Ramsay Générale de Santé · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Lateral Inhibition Therapy (TIL) corrects the patient's hearing by notched amplification on the patient's listening soundtrack. This half-octave notch is targeted at tinnitus frequencies measured tonal. The device slightly increases the amplification around the notch, so that the cerebral cortex compensates for this "gap" in the sound spectrum, masking the crippling tinnitus at the same time. This research is based on a new algorithm developed by the SIEMENS Company which proposes an attenuation of tonal tinnitus by a TIL by notched amplification emitted by the hearing device, object of the study.

Detailed description

In France, up to 16 million people suffer from tinnitus or ringing in the ears daily. This parasitic sound that does not come from the patient's environment can interfere with each individual in a variable way, sometimes creating an insurmountable handicap which has not known any effective treatment validated to date. Lateral Inhibition Therapy (TIL) corrects the patient's hearing by notched amplification on the patient's listening soundtrack. This half-octave notch is targeted at tinnitus frequencies measured tonal. The device slightly increases the amplification around the notch, so that the cerebral cortex compensates for this "gap" in the sound spectrum, masking the crippling tinnitus at the same time. This research is based on a new algorithm developed by the SIEMENS Company which proposes an attenuation of tonal tinnitus by a TIL by notched amplification emitted by the hearing device, object of the study.

Conditions

Interventions

TypeNameDescription
DEVICEAuditory simulationEach patient will be delivered each of the 2 auditory stimulation protocols considered in the context of the research: stimulation with a traditional algorithm called AT and stimulation with a notched-type algorithm called AE. The order in which will be carried out, for the same patient, each of these 2 protocols (AT then AE or AE then AT) will be randomized.

Timeline

Start date
2019-07-19
Primary completion
2021-12-31
Completion
2021-12-31
First posted
2021-03-19
Last updated
2021-03-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04807686. Inclusion in this directory is not an endorsement.